A simple skin blister technique for the study of in vivo transmigration of human leukocytes

2013 ◽  
Vol 393 (1-2) ◽  
pp. 8-17 ◽  
Author(s):  
Lisa Davidsson ◽  
Lena Björkman ◽  
Karin Christenson ◽  
Mikael Alsterholm ◽  
Charlotta Movitz ◽  
...  
1992 ◽  
Vol 22 (4) ◽  
pp. 229-234 ◽  
Author(s):  
B. SKREDE ◽  
R. BLOMHOFF ◽  
G. M. MÆLANDSMO ◽  
L. OSE ◽  
O. MYKLEBOST ◽  
...  

1971 ◽  
Vol 138 (1) ◽  
pp. 369-372 ◽  
Author(s):  
S. Shirakawa ◽  
G. F. Saunders

Author(s):  
Cheng-Ham Wu ◽  
Chia-Hung Hsieh ◽  
Shih-Hung Huang ◽  
Jong-Wei Lin ◽  
Tzung-Dau Wang ◽  
...  

2016 ◽  
Vol 36 (9) ◽  
pp. 910-918 ◽  
Author(s):  
DOC Mariano ◽  
D de Souza ◽  
DF Meinerz ◽  
J Allebrandt ◽  
AF de Bem ◽  
...  

Acquired immunodeficiency syndrome (AIDS) is a worldwide disease characterized by impairments of immune function. AIDS can be associated with oxidative stress (OS) that can be linked to selenium (Se) deficiency. Se is fundamental for the synthesis of selenoproteins, such as glutathione peroxidase and thioredoxin reductase. These enzymes catalyze the decomposition of reactive oxygen species and contribute to maintain equilibrium in cell redox status. Literature data indicate that organoselenium compounds, such as ebselen and diphenyl diselenide, have antioxidant properties in vitro and in vivo models associated with OS. Nevertheless, selenocompounds can also react and oxidize thiols groups, inducing toxicity in mammals. Here, we tested the potential cytotoxic and genotoxic properties of six analogs of the prototypal anti-HIV drug azidothymidine (AZT) containing Se (5′-Se-(phenyl)zidovudine; 5′-Se-(1,3,5-trimethylphenyl)zidovudine; 5′-Se-(1-naphtyl)zidovudine; 5′-Se-(4-chlorophenyl)zidovudine) (C4); 5′-Se-(4-methylphenyl)zidovudine (C5); and 5′-(4-methylbenzoselenoate)zidovudine). C5 increased the rate of dithiothreitol oxidation (thiol oxidase activity) and C2-C4 and C6 (at 100 µM) increased DNA damage index (DI) in human leukocytes. Moreover, C5 (200 µM) decreased human leukocyte viability to about 50%. Taken together, these results indicated the low in vitro toxicity in human leukocytes of some Se-containing analogs of AZT.


Blood ◽  
1960 ◽  
Vol 16 (4) ◽  
pp. 1456-1468 ◽  
Author(s):  
ANTHONY V. PISCIOTTA ◽  
SHIRLEY N. EBBE ◽  
MARY DALY ◽  
MONA RUWALDT ◽  
MILTON GLASER ◽  
...  

Abstract 1. When whole blood was incubated in vitro with S-35 L-cystine and L-methionine, the blood cells became radioactive. 2. Preincubation of whole blood from normals and from patients susceptible to agranulocytosis with chlorpromazine showed no effect upon uptake of S-35 L-cystine and L-methionine by leukocytes. 3. The in vivo administration of S-35 L-cystine was followed by the appearance of radioactive leukocytes. Peak radioactivity occurred in leukocytes in 5 to 12 days. 4. Pretreatment of test subjects with large doses of chlorpromazine did not block the uptake of S-35 L-cystine by leukocytes in vivo. Leukocytes of women showed an increase in the incorporation of S-35 L-cystine, in vivo. Studies performed in vivo on two persons during recovery from agranulocytosis showed enhanced uptake of L-cystine in one and a normal uptake in the other.


2000 ◽  
Vol 105 (4) ◽  
pp. 760-768 ◽  
Author(s):  
Cornelieke M.E.G. Pals ◽  
Sandra A.B.W. Verploegen ◽  
Jan A.M. Raaijmakers ◽  
Jan-Willem J. Lammers ◽  
Leo Koenderman ◽  
...  
Keyword(s):  

Author(s):  
Christian Kretzer ◽  
Blerina Shkodra ◽  
Paul Klemm ◽  
Paul M. Jordan ◽  
Daniel Schröder ◽  
...  

AbstractLeukotrienes are pro-inflammatory lipid mediators generated by 5-lipoxygenase aided by the 5-lipoxygenase-activating protein (FLAP). BRP-201, a novel benzimidazole-based FLAP antagonist, inhibits leukotriene biosynthesis in isolated leukocytes. However, like other FLAP antagonists, BRP-201 fails to effectively suppress leukotriene formation in blood, which limits its therapeutic value. Here, we describe the encapsulation of BRP-201 into poly(lactide-co-glycolide) (PLGA) and ethoxy acetalated dextran (Ace-DEX) nanoparticles (NPs), aiming to overcome these detrimental pharmacokinetic limitations and to enhance the bioactivity of BRP-201. NPs loaded with BRP-201 were produced via nanoprecipitation and the physicochemical properties of the NPs were analyzed in-depth using dynamic light scattering (size, dispersity, degradation), electrophoretic light scattering (effective charge), NP tracking analysis (size, dispersity), scanning electron microscopy (size and morphology), UV–VIS spectroscopy (drug loading), an analytical ultracentrifuge (drug release, degradation kinetics), and Raman spectroscopy (chemical attributes). Biological assays were performed to study cytotoxicity, cellular uptake, and efficiency of BRP-201-loaded NPs versus free BRP-201 to suppress leukotriene formation in primary human leukocytes and whole blood. Both PLGA- and Ace-DEX-based NPs were significantly more efficient to inhibit leukotriene formation in neutrophils versus free drug. Whole blood experiments revealed that encapsulation of BRP-201 into Ace-DEX NPs strongly increases its potency, especially upon pro-longed (≥ 5 h) incubations and upon lipopolysaccharide-challenge of blood. Finally, intravenous injection of BRP-201-loaded NPs significantly suppressed leukotriene levels in blood of mice in vivo. These results reveal the feasibility of our pharmacological approach using a novel FLAP antagonist encapsulated into Ace-DEX-based NPs with improved efficiency in blood to suppress leukotriene biosynthesis.


1982 ◽  
Vol 37 (11-12) ◽  
pp. 1297-1300 ◽  
Author(s):  
Walter R. Paukovits ◽  
Ole D. Laerum

Abstract A peptide was isolated in pure form from human leukocytes which strongly inhibits the proliferation of immature meyloid cells in vitro (committed stem cells). Structural investigations yielded pGlu-Asp or Glu-Asp or Glu-Cys-Lys-OH as the probable sequence of this peptide. The Glu2,Asp3-analog, prepared synthetically, displayed similar activities and when applied in vivo showed effects on the hemopoietic system ranging from an inhibition of pluripotent and committed stem cells to variations in the bone marrow proliferation and alterations in peripheral blood counts.


Sign in / Sign up

Export Citation Format

Share Document